Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea

INTRODUCTION: Sodium glucose co-transporter 2 (SGLT2) inhibitors, such as dapagliflozin, have demonstrated favorable effects in patients with type 2 diabetes (T2D). However, there are limited reports in the literature regarding the glucose-lowering effects of SGLT2 inhibitors in actual clinical sett...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eugene, Kim, Ari, Lee, Sung Jae, Kim, Je-Yon, Kim, Jae Hyeon, Lee, Woo Je, Lee, Byung-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064582/
https://www.ncbi.nlm.nih.gov/pubmed/29998370
http://dx.doi.org/10.1007/s13300-018-0470-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064582/
https://www.ncbi.nlm.nih.gov/pubmed/29998370
http://dx.doi.org/10.1007/s13300-018-0470-9

Ejemplares similares